Vimarsana
Biggest News Aggregation in the World

Page 2 - Interventions Scientific News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Interventions Scientific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Interventions Scientific Today - Breaking & Trending Today

Ticagrelor monotherapy after PCI poses no extra revascularization risk vs. continued DAPT - Vimarsana News

Ticagrelor monotherapy after PCI poses no extra revascularization risk vs. continued DAPT

Ticagrelor monotherapy after 3-month dual antiplatelet therapy was not associated with greater risk for repeat revascularization or MACCE at 1 year after PCI vs. continued DAPT, a speaker reported. The TWILIGHT trial, for which the main results were presented at TCT 2019, evaluated the efficacy and safety of ticagrelor plus aspirin compared with ticagrelor alone for bleeding and ischemic

Source: healio.com
Distal artery access PCI safe vs. proximal access at 1 year; no impact on hand function - Vimarsana News

Distal artery access PCI safe vs. proximal access at 1 year; no impact on hand function

Distal radial artery access for PCI showed no significant change in hand function and similar rates of access-site bleeding and radial artery occlusion at 1 year vs. proximal access, a speaker reported.The 1-year outcomes of the DIPRA trial were presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

Source: healio.com
Mechanical circulatory support protocol beneficial in acute MI, cardiogenic shock - Vimarsana News

Mechanical circulatory support protocol beneficial in acute MI, cardiogenic shock

Mechanical circulatory support protocol beneficial in acute MI, cardiogenic shock Source: Basir MB, et al. Featured Clinical Research: Acute coronary and cardiogenic shock. Presented at: Society for Cardiovascular Angiography and Interventions Scientific Sessions; April 28-May 1, 2021 (virtual meeting). Disclosures: The study was funded in part by Abiomed and Chiesi. Basir reports he consults for Abbott Vascular, Abiomed, Cardiovascular Systems Inc., Chiesi, Procyrion and Zoll. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on ...

Source: healio.com